vivatec 5 mg tabletti
merck sharp & dohme b.v. - lisinoprilum dihydricum - tabletti - 5 mg - lisinopriili
vivatec 10 mg tabletti
merck sharp & dohme b.v. - lisinoprilum dihydricum - tabletti - 10 mg - lisinopriili
vivatec 20 mg tabletti
merck sharp & dohme b.v. - lisinoprilum dihydricum - tabletti - 20 mg - lisinopriili
vivatec comp 20 mg / 12.5 mg tabletti
merck sharp & dohme b.v. - hydrochlorothiazidum,lisinoprilum dihydricum - tabletti - 20 mg / 12.5 mg - lisinopriili ja diureetit
vivatec 2.5 mg tabletti
merck sharp & dohme b.v. - lisinoprilum anhydricum - tabletti - 2.5 mg - lisinopriili
ketorolac s.a.l.f. 30 mg/ml injektioneste, liuos
salf spa laboratorio farmacologico - ketorolac trometamol - injektioneste, liuos - 30 mg/ml - ketorolaakki
lidokain mylan 10 mg/ml injektioneste, liuos
mylan ireland limited - lidocaine hydrochloride monohydrate - injektioneste, liuos - 10 mg/ml - lidokaiini
lidokain mylan 20 mg/ml injektioneste, liuos
mylan ireland limited - lidocaine hydrochloride monohydrate - injektioneste, liuos - 20 mg/ml - lidokaiini
labetalol s.a.l.f. 5 mg/ml injektio-/infuusioneste, liuos
salf spa laboratorio farmacologico - labetalol hydrochloride - injektio-/infuusioneste, liuos - 5 mg/ml - labetaloli
iasibon
pharmathen s.a. - ibandronihappo - hypercalcemia; fractures, bone; neoplasm metastasis; breast neoplasms - lääkkeet luusairauksien hoitoon - concentrate for solution for infusion prevention of skeletal events (pathological fractures, bone complications requiring radiotherapy or surgery) in patients with breast cancer and bone metastases. kasvainten aiheuttaman hyperkalsemian hoitoon tai ilman etäpesäkkeitä. film-coated tablets prevention of skeletal events (pathological fractures, bone complications requiring radiotherapy or surgery) in patients with breast cancer and bone metastases.